Carbonic anhydrase inhibitors. Part 89 1 metal complexes of benzolamide with strong enzyme inhibitory and putative antiulcer properties

Revue Roumaine de Chimie

Volumn 45, Issue 7-8, 2000, Pages 771-778

  Scozzafava, Andrea ^a   Ilieş, Marc A ^b   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF AGRONOMIC SCIENCES AND VETERINARY MEDICINE OF BUCHAREST   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042260553     PISSN: 00353930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Part 88 of the series: C. T. Supuran, F. Briganti, S. Tilli, W. R. Chegwidden, A. Scozzafava, J. Med Chem., 2000, 43, in press.
2. a) C. T. Supuran, F. Mincione, A. Scozzafava, F. Briganti, G. Mincione, M. A. Ilieş, Eur. J. Med. Chem, 1998, 33, 247-254;
3. b) C. T. Supuran, A. Scozzafava, A. Jitianu, Metal Based Drugs, 1997, 4, 307-315;
4. c) C. T. Supuran, A. Scozzafava, F. Mincione, L. Menabuoni, F. Briganti, G. Mincione, M. Jitianu, Eur. J. Med. Chem, 1999, 34, 585-594.
5. C. T. Supuran, in Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism, I. Puşcaş Ed., Helicon, Timişoara, 1994, p. 29-111.
6. G. Alzuet, S. Ferrer, J. Borras, C. T. Supuran, Roum. Chem. Quart. Rev., 1994, 2, 283-300.
7. a) C. T. Supuran, M. Andruh, I. Puşcaş, Rev. Roum. Chim., 1990, 35, 393-398;
8. b) S. Ferrer, A. Jimenez J. Borras, Inorg. Chim. Acta, 1987, 129, 103-106;
9. c) S. Ferrer, G. Alzuet, J. Borras, J. Inorg. Biochem., 1989, 37, 163-174;
10. d) C. T. Supuran G. Manole, I. Mânzatu, Rev. Roum. Chim., 1992, 37, 739-744.
11. a) C. T. Supuran, G. Manole, M. Andruh, J. Inorg. Biochem., 1993, 49, 97-104:
12. b) G. Alzuet, S. Ferrer, J. Borras, A. Castineiras, X. Solans, M. Font-Bardia, Polyhedron, 1992, 11, 2849-2856;
13. c) C. T. Supuran, M. Andruh, Rev. Roum. Chim., 1994, 39, 1229-1234.
14. a) M. Andruh, E. Cristurean, R. Ştefan, C. T. Supuran, Rev. Roum. Chim., 1991, 36, 1727-1732;
15. b) C. T. Supuran, G. Loloiu, G. Manole, Rev. Roum. Chim., 1992, 37, 1181-1189.
16. a) C. T. Supuran, Metal Based Drugs, 1995, 2, 327-330;
17. b) L. Sumalan, J. Casanova, G. Alzuet, J. Borras, A. Castineiras, C. T. Supuran, J. Inorg. Biochem., 1996, 62, 31-39.
18. G. Mincione, A. Scozzafava, C. T. Supuran, Metal Based Drugs, 1997, 4, 27-34.
19. G. Alzuet, S. Ferrer-Llusar, J. Borras, J. Server-Carrió, R. Martínez-Máñez J. Inorg. Biochem., 1999, 75, 189-198.
20. a) M. B. Standen, J. M. Quayle, N. W. Davies, J. E. Brayden, Y. Huang, M. T. Nelson, Science, 1989, 245, 177-180;
21. b) J. G. Gerben A. S. Nies, in The Pharmacological Basis of Therapeutics, 8th Edition, A. G. Gilman, T. W. Rall, A. S. Nies and P. Taylor Eds., Pergamon Press, New York, 1990, p. 784-813;
22. c) S. R. Levin, M. A. Charles, M. O'Connor, G. M. Grodsky, Am. J. Physiol. 1975, 299, 49-54;
23. d) C. R. Kahn, Y. Schechter, in The Pharmacological Basis of Therapeutics, 8th Edition, A. G. Gilman, T. W. Rall, A. S. Nies and P. Taylor Eds., Pergamon Press, New York, 1990, p. 1463-1495.
24. a) F. C. Novello, J. M. Sprague, J. Am. Chem. Soc., 1957, 79, 2028-2029;
25. b) K. H. Beyer, J. E. Baer, Pharmacol. Rev., 1961, 13, 517-562;
26. c) I. M. Weiner, in The Pharmacological Basis of Therapeutics, 8th Edition, A. G. Gilman, T. W. Rall, A. S. Nies and P. Taylor Eds., Pergamon Press, New York, 1990, p. 713-732.
27. a) J. Borras, A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione, C. T. Supuran, Bioorg. Med. Chem., 1999, 7, 2397-2406;
28. b) A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione, C. T. Supuran, J. Med. Chem., 1999, 42, 2641-2650;
29. c) A. Scozzafava, F. Briganti, G. Mincione, L. Menabuoni, F. Mincione, C. T. Supuran, J. Med. Chem., 1999, 42, 3690-3700.
30. T. H. Maren, Benzolamide - a renal carbonic anhydrase inhibitor. In Orphan Drugs, F. E. Karch ed., Dekker, New York, 1982, p. 89-115.
31. a) C. T. Supuran, A. Scozzafava, I. Şaramet, M. D. Banciu, J. Enzyme Inhib. 1998, 13, 177-194;
32. b) C. T. Supuran A. Scozzafava, J. Enz. Inhib., 1997, 12, 37-51;
33. c) C. T. Supuran, F. Briganti, A. Scozzafava, J. Enz. Inhib., 1997, 12, 175-190.
34. a) C. T. Supuran, A. Popescu, M. Ilişiu, A. Costandache, M. D. Banciu, Eur. J. Med. Chem., 1996, 31, 439-447;
35. b) C. T. Supuran, A. Scozzafava, A. Popescu, R. Bobeş-Tureac, A. Banciu, A. Creangǎ, G. Bobeş-Tureac, M. D. Banciu, Eur. J. Med. Chem., 1997, 32, 445-452;
36. c) A. Popescu, A. Simion, A. Scozzafava, F. Briganti, C. T. Supuran, J. Enz. Inhib., 1999, 14, 407-423.
37. a) A. Scozzafava, C. T. Supuran, J. Enz. Inhib. 1998, 13, 103-123;
38. b) C. T. Supuran, A. Scozzafava, B. C. Jurcǎ, M. A. Ilieş, Eur. J. Med. Chem., 1998, 33, 83-93.
39. G. S. Ponticello, M. F. Sugrue, B. Plazonnet, G. Durand-Cavagna, Pharm. Biotechnol. 1998, 11, 555-574.
40. B. W. Clare, C. T. Supuran, Eur. J. Med. Chem. 1999, 34, 463-474.
41. Y. Pocker and J. T. Stone, Biochemistry, 1967, 6, 668-679.
42. Lambling, A., Bernier, J. J., Badoz-Lambling, J. Arch. Mal. App. Dig. Nutr. 1960, 9, 1000-1007.
43. Kovacs, T. O., Lloyd, K. C., Walsh, J. H. Peptides 1996, 17, 583-587.
44. Uchiyama, K., Wakatsuki, D., Kakinoki, B., Takeuchi, Y., Araki, T. Morinaka, Y. J. Pharm. Pharmacol. 1995, 51, 457-464.
45. Takemoto, Y., Yuki, H., Nishida, A., Ito, H.,Kobayashi-Uchida, A., Takinami, Y., Akuzawa, S., Ohta, M., Satoh,M., Semple, G., Miyata, K. Arzneimittelforschung 1998, 48, 403-407.
46. A. Scozzafava, F. Briganti, M. A. Ilieş, C.T. Supuran, J. Med. Chem. 2000, 43, 292-300.
47. C. T. Supuran, M. A. Ilieş, A. Scozzafava, Eur. J. Med. Chem. 1998, 33, 739-752.
48. H. Abdine, M. A. Elsayed, Y. M. Elsayed, J. Assoc. Off. Anal. Chem. 1978, 61, 695-701.
49. a) G. Alzuet, J. Casanova, J. Borras, S. Garcià-Granada, A. Gutiérrez-Rodriguez, C .T. Supuran, Inorg. Chim. Acta, 1998, 273, 334-338;
50. b) P. Borja, G. Alzuet, J. Server-Carrió, J. Borras, C.T. Supuran, Main Group Met, Chem., 1998, 21, 279-292.
51. A. Y. Louie, T. J. Meade, Chem. Rev. 1999, 99, 2711-2734.
52. I. Puşcaş, C. T. Supuran, Farmacologia clinica da ulcera peptica in Aparelho Digestivo, J. Coelho Ed., MEDSI, Rio de Janiero, 1996, pp. 1704-1734 (in Portuguese).
53. a) M. Ljungstrom, F. V. Vega, S. Mardh, Biochim. Biophys. Acta 1984, 769, 220-230;
54. b) M. A. Read, D. M. Read, M. Kapuscinski, A. Shulkes, Regul. Pept. 1992, 40, 13-27;
55. c) R. E. Fleming, S. Parkkila, A. K. Parkkila, H. Rajaniemi, A. Waheed, W. S. Sly J. Clin. Invest. 1995, 96, 2907-2913.
56. a) M. Kapuscinski, A shulkes, J. Gastroenterol. Hepatol. 1995, 10, 405-412;
57. b) V. W. Campbell, T. Yamada, Am. J. Physiol., 1991, 260, G434-439;
58. c) V.W. Campbell, T. Yamada, J. Biol. Chem. 1989, 264, 11381-11386.
59. L. L. Brunton, Drugs affecting gastointestinal function, in The Pharmacological Basis of Therapeutics, 8th Edition, A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor Eds., Pergamon Press, New York, 1990, p. 897-913.
60. M. A. Ilieş, C. T. Supuran, A. Scozzafava, Metal Based Drugs, 2000, in press.